These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: Hsa-miR-499 polymorphism (rs3746444) and cancer risk: a meta-analysis of 17 case-control studies. Author: Wang Y, Yang B, Ren X. Journal: Gene; 2012 Nov 10; 509(2):267-72. PubMed ID: 22922391. Abstract: INTRODUCTION: MicroRNAs (miRNAs) are a family of endogenous, small and noncoding RNAs that negatively regulate gene expression by suppressing translation or degrading mRNAs. Recently, many studies investigated the association between hsa-miR-499 rs3746444 polymorphism and cancer risk, which showed inconclusive results. METHODOLOGY/MAIN RESULTS: We conducted a meta-analysis of 17 studies that included 7842 cancer cases and 8989 case-free controls and assessed the strength of the association, using odds ratios (ORs) with 95% confidence intervals (CIs). Overall, hsa-miR-499 rs3746444 polymorphism was associated with higher cancer risk in heterozygote model (AG vs AA, OR=1.15, 95%CI=1.01-1.30, P(heterogeneity)<0.001), dominant genetic model (GG/AG vs AA, OR=1.18, 95% CI=1.04-1.33, P(heterogeneity)<0.001) and allele contrast (G vs A, OR=1.09, 95% CI=1.01-1.18, P(heterogeneity)=0.021). In the stratified analyses, we observed that the GG/AG genotype might modulate breast cancer risk (OR=1.13, 95% CI=1.01-1.26, P(heterogeneity)=0.111) comparing with the AA genotype. Moreover, a significantly increased risk was found among Asian populations in heterozygote model (AG vs AA, OR=1.23, 95% CI=1.06-1.43, P(heterogeneity)<0.001), homozygote model (GG vs AA, OR=1.22, 95% CI=1.02-1.46, P(heterogeneity)=0.319), dominant model (GG/AG vs AA, OR=1.25, 95% CI=1.06-1.39, P(heterogeneity)<0.001) and allele contrast (G vs A, OR=1.14, 95% CI=1.04-1.25, P(heterogeneity)=0.021). CONCLUSIONS: These findings supported that hsa-miR-499 rs3746444 polymorphism contributes to the susceptibility of cancers.[Abstract] [Full Text] [Related] [New Search]